Abcellera Biologics Inc at Bloom Burton & Co. Healthcare Investor Conference Transcript
Welcome to the 2022 Bloom Burton Healthcare Investment Conference this morning. You are in Hall C and D, which is a large hall. This morning, we have a series of sessions, series of presentations with biotech companies. We will have also a fireside chat midway through with BELLUS Health. But to start, we have Carl Hansen here, Chairman, CEO and President of AbCellera Biologics. Carl, take it away.
All right, thank you so much. Can everyone hear me? Great. So first, let me say what a pleasure it is to finally be back in three dimensions after three years. We had a terrific dinner last night and conversation, got to meet many of the people that I've only met through Zoom, and also to reconnect with some old friends. I really think that Canada has a remarkable community in terms of the support and people cheering for each other across the country. And it's really heartwarming to be back, back in that event, and so I wanted to thank the team of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |